Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

NCT02723955 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

829

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: feladilimab (GSK3359609)
DRUG: GSK3174998
DRUG: Pembrolizumab
DRUG: Docetaxel
DRUG: Pemetrexed
DRUG: Paclitaxel plus Carboplatin
DRUG: Gemcitabine plus Carboplatin
DRUG: Fluorouracil (5-FU) plus carboplatin or cisplatin
DRUG: Dostarlimab
DRUG: Cobolimab
DRUG: Bintrafusp alfa

Sponsor

GlaxoSmithKline

Collaborators

[object Object]